These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 19292042)
1. [Expression of glucose transporter 1 in human breast carcinoma and its clinical significance]. Hao LS; Ni Q; Jia GQ; Wang G; Qian K; Liu YJ; Zhang Y; Wu XT Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):44-7. PubMed ID: 19292042 [TBL] [Abstract][Full Text] [Related]
2. [HIF-1alpha expression and relationship involving tumor cell proliferation and angiogenesis in human breast carcinoma]. Hao LS; Wang G; Qian K; Luo T; Li XJ; Wu XT Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):60-3. PubMed ID: 17294729 [TBL] [Abstract][Full Text] [Related]
3. [Expression of glucose transporter-1 and its correlation with basic fibroblast growth factor and proliferating cell nuclear antigen in epithelial ovarian neoplasm]. Zhao SJ; Liu JY; Ren FR; Feng YJ Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):264-8. PubMed ID: 15924676 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Alò PL; Visca P; Botti C; Galati GM; Sebastiani V; Andreano T; Di Tondo U; Pizer ES Am J Clin Pathol; 2001 Jul; 116(1):129-34. PubMed ID: 11447743 [TBL] [Abstract][Full Text] [Related]
5. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade. Mommers EC; Leonhart AM; Falix F; Michalides R; Meijer CJ; Baak JP; Diest PJ J Pathol; 2001 Jul; 194(3):327-33. PubMed ID: 11439365 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast. Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596 [TBL] [Abstract][Full Text] [Related]
8. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090 [TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53]. Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603 [TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases. Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736 [TBL] [Abstract][Full Text] [Related]
11. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance]. Hu SE; Zhang YJ; Cui YM; Zhang HQ Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428 [TBL] [Abstract][Full Text] [Related]
12. bcl-2 expression in the spectrum of preinvasive breast lesions. Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957 [TBL] [Abstract][Full Text] [Related]
13. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma]. Zhou YL; Deng CS Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479 [TBL] [Abstract][Full Text] [Related]
14. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238 [TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 and associated proteins in mammary ductal carcinoma in situ and atypical ductal hyperplasia. Gillett CE; Lee AH; Millis RR; Barnes DM J Pathol; 1998 Apr; 184(4):396-400. PubMed ID: 9664905 [TBL] [Abstract][Full Text] [Related]
16. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53. Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265 [TBL] [Abstract][Full Text] [Related]
17. Stage-specific expression of breast cancer-specific gene gamma-synuclein. Wu K; Weng Z; Tao Q; Lin G; Wu X; Qian H; Zhang Y; Ding X; Jiang Y; Shi YE Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):920-5. PubMed ID: 14504205 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of E-cadherin in sclerosing adenosis, ductal carcinoma in situ and invasive ductal carcinoma of the breast. Facina G; Lopes-Costa PV; Dos Santos AR; De Vasconcelos-Valença RJ; Pinho-Sobral AL; Ferreira-Filho CP; Alencar AP; Gebrim LH; Da Silva BB Diagn Cytopathol; 2010 Apr; 38(4):235-8. PubMed ID: 19790246 [TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259 [TBL] [Abstract][Full Text] [Related]
20. [Loss of fragile histidine triad expression and metastasis in breast cancer]. Zhao P; Li XY; Chen LZ Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]